VRAX
Virax Biolabs Group Limited$0.18
LiveJun 12, 2026
Market cap
$798.92K
52w range
0.10 – 1.14
P / E
—
EPS
—
Volume
721.67K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Virax Biolabs Group Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $1.00 (+443.48%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.88% | -7.30% | +31.43% | -3.66% | -59.46% | -46.79% | -78.86% | -96.31% | -99.90% | -99.90% | -99.90% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$0.18
Bid
$0.17
190 sh
Ask
$0.20
50 sh
Spread
$0.027
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for VRAX.
Peers
No peer list available for VRAX.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|